ABSTRACT OBJECTIVES This study was intended to evaluate the impact of adding the left atrial appendage (LAA) closure system (LARIAT) procedure to conventional atrial fibrillation (AF) ablation in patients with persistent AF.
Because the LAA has an "electrical role" in persistent AF and the LARIAT procedure can result in "electrical exclusion" of LAA, we proposed that addition of LAA exclusion with the LARIAT to conventional AF ablation in patients with persistent AF may improve the success rate of the ablation procedure (9) (10) (11) (12) (13) .
METHODS
PATIENT POPULATION. We performed a prospective, multicenter, observational study of patients who were referred for ablation of persistent AF. The protocol was approved by all the participating institutions' institutional review boards. After evaluating the following inclusion and exclusion criteria, patients referred for persistent AF ablation (with or without prior ablation) were considered for the LARIAT procedure for LAA exclusion as an adjunct to AF ablation.
Patients for the LARIAT procedure were screened using the following inclusion criteria: 1) age 18 years or older; 2) persistent nonvalvular AF; 3) at least 1 risk factor of embolic stroke (CHADS 2 $1); and 4) a life expectancy of at least 1 year. Patients were excluded from the study if they met any of the following exclusion criteria: 1) history of cardiac surgery; 2) unfavorable chest anatomy (pectus excavatum); 3) recent myocardial infarction (within 3 months); 4) embolic event within the past 30 days; 5) New York Heart Association functional class IV heart failure symptoms; and 6) history of thoracic radiation. Patients who gave informed consent had their computed tomography scan of the heart evaluated for suitability for LARIAT procedure. Exclusion criteria based on LAA anatomy included: 1) a LAA width >40 mm; 2) a superiorly oriented LAA with the LAA apex directed behind the pulmonary trunk;
3) bilobed LAA or multilobed LAA in which lobes were oriented in different planes exceeding 40 mm; and 4) a posteriorly rotated heart. After excluding patients (n ¼ 18) who were not candidates for LARIAT, a total of 69 patients successfully underwent a protocol-driven LARIAT procedure (LARIAT group) from January 2012 through December 2013. All of these patients then underwent a conventional AF ablation procedure at least 30 days later, primarily involving pulmonary vein antral isolation. We prospectively included an equal number of age-and sex-matched patients with persistent AF undergoing AF ablation during the same time frame as a control group of the study (ablation-only group).
PERCUTANEOUS SUTURE EXCLUSION OF THE LAA
USING THE LARIAT DEVICE. LAA exclusion was performed using the standard protocol for LARIAT device implantation as previously described (6) . In brief, 
Role of LAA Ligation on Outcome of AF Ablation 
RESULTS
BASELINE DATA. A total of 138 patients were included in the study, with 69 in each group. Baseline characteristics are described in Table 1 Values are mean AE SD or n (%). Baseline LA volumes were comparable between the groups. Post-procedural LA volume was much less in the LARIAT group compared with the ablation-only group (129 AE 32 ml vs. 149 AE 30 ml; p < 0.001) ( Figure 5 ). Two (3%) patients had a transient ischemic attack in the ablation-only group after discontinuing anticoagulation from recurrent silent AF.
DISCUSSION
In our prospective multicenter study, we found that addition of the LARIAT procedure to catheter ablation for patients in persistent AF was associated with a significant decrease in the recurrence of AF. 
